Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P78504: Variant p.Leu37Ser

Protein jagged-1
Gene: JAG1
Feedback?
Variant information Variant position: help 37 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Leucine (L) to Serine (S) at position 37 (L37S, p.Leu37Ser). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and hydrophobic (L) to small size and polar (S) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In ALGS1; the mutant is unable to activate Notch signaling. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 37 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1218 The length of the canonical sequence.
Location on the sequence: help LLALLCALRAKVCGASGQFE L EILSMQNVNGELQNGNCCGG The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         LLALLCALRAKVCGASGQFELEILSMQNVNGELQNGNCCGG

Mouse                         LLALLCALRAKVCGASGQFELEILSMQNVNGELQNGNCCGG

Rat                           LLALLCALRAKVCGASGQFELEILSMQNVNGELQNGNCCGG

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 34 – 1218 Protein jagged-1
Topological domain 34 – 1067 Extracellular
Alternative sequence 1 – 159 Missing. In isoform 2.
Beta strand 33 – 43



Literature citations
Defective intracellular transport and processing of JAG1 missense mutations in Alagille syndrome.
Morrissette J.J.D.; Colliton R.P.; Spinner N.B.;
Hum. Mol. Genet. 10:405-413(2001)
Cited for: VARIANT ALGS1 SER-37; Mutation analysis of Jagged1 (JAG1) in Alagille syndrome patients.
Colliton R.P.; Bason L.; Lu F.-M.; Piccoli D.A.; Krantz I.D.; Spinner N.B.;
Hum. Mutat. 17:151-152(2001)
Cited for: VARIANTS ALGS1 ASP-33; SER-37; SER-78; ASN-181; TYR-714 AND SER-902; Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis.
Bauer R.C.; Laney A.O.; Smith R.; Gerfen J.; Morrissette J.J.; Woyciechowski S.; Garbarini J.; Loomes K.M.; Krantz I.D.; Urban Z.; Gelb B.D.; Goldmuntz E.; Spinner N.B.;
Hum. Mutat. 31:594-601(2010)
Cited for: VARIANTS SER-664 AND GLN-1104; CHARACTERIZATION OF VARIANT SER-664; VARIANT TOF LEU-810; CHARACTERIZATION OF VARIANTS TOF ASP-274 AND LEU-810; CHARACTERIZATION OF VARIANTS ALGS1 SER-37 AND GLN-937; CHARACTERIZATION OF VARIANT DCHE TYR-234; FUNCTION;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.